Saturday, October 25, 2014

Hot Managed Healthcare Stocks To Watch For 2014

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of specialty chemical maker American Vanguard (NYSE: AVD  ) fell 17% today after cautioning about second-quarter earnings.

So what: Wet weather in the Midwest and Southeast will negatively affect the company's performance in the second quarter and the company doesn't expect to meet either top- or bottom-line expectations. Revenue is expected to top last year's $84.8 million but won't hit Wall Street's $106.8 million expectation. �

Now what: American Vanguard didn't give an update on what profit would look like, but investors are expecting the worst. Some of these sales will not only be delayed but will also be lost altogether, and that's the biggest concern today. But long-term this isn't a blow to the company's market share and weather won't have this kind of impact every year. The stock trades at 14.7 time trailing earnings now, and considering that revenue will still grow despite bad weather, I think this is a buying opportunity for long-term investors.

Interested in more info on American Vanguard? Add it to your watchlist by clicking here.

Hot Airline Companies To Invest In Right Now: Dyax Corp.(DYAX)

Dyax Corp., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel biotherapeutics for unmet medical needs in the United States. The company utilizes its proprietary drug discovery technology, known as phage display, to identify antibody, small protein, and peptide compounds. It markets KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older. Dyax Corp. also provides KALBITOR Access program, which offers treatment support service for patients with HAE and their healthcare providers. In addition, the company is developing a pipeline of 17 product candidates, including 4 product candidates in Phase III clinical trial, 4 product candidates in Phase II clinical trial, and 9 product candidates in Phase 1 clinical trial for the treatment of atherosclerosis, multiple sclerosis, and oncology diseases. Further, it provides library licenses to use its phage display libr aries in connection with their internal therapeutic development programs; performs funded research for various collaborators; and offers patent licenses to other biopharmaceutical and pharmaceutical companies to use its phage display patents to discover and develop biologic compounds for use in specified fields. The company has strategic partnership agreement with Defiante Farmaceutica S.A. to develop and commercialize subcutaneous ecallantide for the treatment of HAE and other therapeutic indications in Europe, North Africa, the Middle East, and Russia; an agreement with CMIC Co., Ltd to develop and commercialize subcutaneous ecallantide for the treatment of HAE and other angioedema indications in Japan; and an license and collaboration agreement with Cubist Pharmaceuticals, Inc. to develop and commercialize the formulation of ecallantide for the reduction of blood loss during surgery in North America and Europe. Dyax Corp. was founded in 1989 and is headquartered in Cambri dge, Massachusetts.

Advisors' Opinion:
  • [By Travis Hoium]

    What: Shares of Dyax (NASDAQ: DYAX  ) lost 34% of their value today, falling off a cliff after first-quarter earnings came out.

    So what: First-quarter net sales increased slightly from a year ago, to $12.0 million, but analysts expected $16.0 million in revenue, so this is a huge miss. It's no wonder that net loss of $11.2 million equates to $0.11 per share, more than double the $0.05 per share loss analysts expected.�

  • [By Brian Orelli]

    Dyax (NASDAQ: DYAX  ) and its investors will also be keeping a close eye on trebananib's development. The biotech helped Amgen discover trebananib and is due milestone payments for successful development of the drug.

Hot Managed Healthcare Stocks To Watch For 2014: Washington Federal Inc (WAFD)

Washington Federal, Inc., incorporated on November 15, 1994, is a bank holding company, which conducts its operations through a federally-insured savings association subsidiary, Washington Federal (Bank). The Bank is a federal savings association. The business of the Bank consists of attracting deposits from the general public and investing these funds in loans of various types, including first lien mortgages on single-family dwellings, construction loans, land acquisition and development loans, loans on multi-family and other income producing properties, home equity loans and business loans. It also invests in United States government and agency obligations and other investments permitted by applicable laws and regulations. As of September 30, 2013, Washington Federal had 182 full service branches located in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico and Texas. Through its subsidiaries, the Company is also engaged in real estate investment and insurance brokerage activities. The principal sources of funds for the Company's activities are retained earnings, loan repayments (including prepayments), net deposit inflows, repayments and sales of investments and borrowings. Washington Federal's principal sources of revenue are interest on loans and interest and dividends on investments. Its principal expenses are interest paid on deposits, credit costs, general and administrative expenses, interest on borrowings and income taxes. On October 31, 2012, South Valley Bancorp, Inc. merged with and into the Company, followed by the merger of South Valley's wholly owned subsidiary, South Valley Bank & Trust, into the Bank.

Lending Activities

As of September 30, 2013, the Company's net portfolio of loans totaled $7.5 billion representing approximately 58% of its total assets. The Company concentrates its lending activities on the origination of 30-year, fixed-rate mortgage loans, which are neither insured nor guaranteed by agencies of the United States government. Washin! gton Federal's lending activity is concentrated on the origination of loans secured by real estate, including long-term fixed-rate mortgage loans, adjustable-rate construction loans, adjustable-rate land development loans, fixed-rate multi-family loans and business loans.

The Company's lending activity is the origination of real estate mortgage loans to purchase or refinance single-family residences. The Company also originates a range of construction and land development loans, along with multi-family residential and commercial loans. As of September 30, 2013, single-family residential loans totaled $5.4 billion, or 67.2% of the Company's gross loan portfolio; construction- speculative loans totaled$131 million, or 1.6% of the Company's gross loan portfolio; construction - custom loans totaled $303 million, or 3.8% of the Company's gross loan portfolio; land acquisition and development loans totaled $82 million, or 1.0% of the Company's gross loan portfolio; land - consumer lot loans totaled $125 million, or 1.6% of the Company's gross loan portfolio; multi-family loans totaled $836 million, or 10.5% of the Company's gross loan portfolio; commercial real estate loans totaled $625 million, or 7.8% of the Company's gross loan portfolio; commercial and industrial loans totaled $326 million, or 4.1% of the Company's gross loan portfolio; home equity line of credit (HELOC) loans totaled $134 million, or 1.7% of the Company's gross loan portfolio and consumer loans totaled $55 million, or 0.7% of the Company's gross loan portfolio.

The Company originates 30 year fixed-rate loans secured by single-family residences. The Company originates construction loans to finance construction of single-family and multi-family residences, as well as commercial properties. Loans made to individuals for construction of their home generally are 30 year fixed rate loans. Multi-family residential (five or more dwelling units) loans are secured by multi-family rental properties, such as apartment build! ings.

!

The Company makes various types of business loans to customers in its market area for working capital, acquiring real estate, equipment or other business purposes, such as acquisitions. The terms of these loans range from less than one year to a maximum of 10 years. Consumer loans are home improvement loans made through third party originators that bear interest at rates of 10% and higher.

Investment Activities

As a federal association, the Bank is obligated to maintain adequate liquidity and does so by holding cash and cash equivalents and by investing in securities. These investments include, among other things, certain certificates of deposit, repurchase agreements, bankers��acceptances, loans to financial institutions whose deposits are federally-insured, federal funds, United States government and agency obligations and mortgage-backed securities.

Sources of Funds

Deposits are the source of the Company�� funds for use in lending and other general business purposes. In addition to deposits, Washington Federal derives funds from loan repayments, advances from the Federal Home Loan Bank (FHLB) and other borrowings and from investment repayments and sales. The Company�� deposits are obtained from residents of Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico and Texas. The Company obtains advances from the FHLB upon the security of the FHLB capital stock it owns and certain of its loans, provided certain standards related to credit worthiness have been met. The Company also uses reverse repurchase agreements as a form of borrowing. Under reverse repurchase agreements, the Company sells an investment security to a dealer for a period of time and agrees to buy back that security at the end of the period and pay the dealer a stated interest rate for the use of the dealer's funds. The Company also offers two forms of repurchase agreements to its customers. One form has an interest rate, which floats like that of a money market d! eposit ac! count. The other form has a fixed rate and is offered in a minimum denomination of $100,000. Both forms are fully collateralized by securities. As of September 30, 2013, the Company had $46.1 million of such agreements outstanding.

Advisors' Opinion:
  • [By Eric Volkman]

    Washington Federal (NASDAQ: WAFD  ) is keeping its dividend level even as it effects a corporate transformation by the end of next month. The company has declared a quarterly distribution of $0.09 per share, to be paid on July 19 to shareholders of record as of July 5. That amount matches the firm's previous distribution, which was paid in April. Prior to that, it handed out a penny less at $0.08 per share.

  • [By Brian Pacampara]

    What: Shares of financial holding company Washington Federal (NASDAQ: WAFD  ) climbed as high as 10% today after its quarterly results topped Wall Street expectations.�

Hot Managed Healthcare Stocks To Watch For 2014: Pendrell Corp (PCO)

Pendrell Corporation (Pendrell), formerly ICO Global Communications (Holdings) Limited, incorporated on March 17, 2000, is a fully-integrated intellectual property (IP) investment and advisory company. The Company develops and implements strategies to create, acquire, commercialize and license IP. The Company provides IP valuation services, analysis and strategic advice through Pendrell�� wholly owned subsidiary, Pendrell Technologies LLC (PTL) and its wholly owned subsidiary, Ovidian Group LLC (Ovidian Group). It also assists its clients with a rangeof IP services, including IP valuation and investment analysis, IP landscape analysis, IP divestitures and IP risk mitigation strategies. On June 17, 2011, the Company acquired Ovidian Group. On October 31, 2011, the Company�� subsidiary, Pendrell Technologies LLC, acquired 90.1% interest in ContentGuard Holdings, Inc. In November 2011, Technicolor SA sold its 25.7% interest in ContentGuard to Pendrell Technologies LLC, a wholly owned subsidiary of Pendrell Corporation. During the year ended December 31, 2011, the Company completed the divestiture of its satellite communications assets. Effective February 25, 2013, the Company acquired 68% interest in Provitro Biosciences LLC.

The Company competes with Acacia Research Corporation, Coller IP Management, Intellectual Ventures, Mosaid, Rovi, RPX, Wi-Lan, Boston Consulting Group, Bain & Company and Red Chalk Group.

Advisors' Opinion:
  • [By Roberto Pedone]

    Pendrell (PCO) is a fully integrated intellectual property investment and advisory firm. This stock closed up 2.3% to $2.18 in Tuesday's trading session.

    Tuesday's Range: $2.08-$2.22

    52-Week Range: $1.04-$2.71

    Tuesday's Volume: 263,000

    Three-Month Average Volume: 457,962

    From a technical perspective, PCO bounced higher here back above its 50-day moving average of $2.16 with lighter-than-average volume. This move is quickly pushing shares of PCO within range of triggering a near-term breakout trade. That trade will hit if PCO manages to take out some near-term overhead resistance at $2.22 with high volume.

    Traders should now look for long-biased trades in PCO as long as it's trending above Tuesday's low of $2.08 or above $2 and then once it sustains a move or close above $2.22 with volume that hits near or above 457,962 shares. If that breakout triggers soon, then PCO will set up to re-test or possibly take out its next major overhead resistance levels at $2.50 to its 52-week high at $2.71.

Hot Managed Healthcare Stocks To Watch For 2014: Guggenheim CurrencyShares Japanese Yen Trust (FXY)

Guggenheim CurrencyShares Japanese Yen Trust, formerly CurrencyShares Japanese Yen Trust, is a grantor trust. The Trust issues shares (the Shares) in blocks of 50,000 (a Basket) in exchange for deposits of Japanese Yen and distributes Japanese Yen in connection with the redemption of Baskets. The investment objective of the Trust is for the Shares to reflect the price of Japanese Yen plus accrued interest, if any, less the expenses of the Trust�� operations. The Trust holds Japanese Yen and, from time to time, issues Baskets in exchange for deposits of Japanese Yen and distributes Japanese Yen in connection with redemptions of Baskets. The Sponsor of the Trust is Guggenheim Specialized Products, LLC, a Delaware limited liability company.

The Bank of New York Mellon, a banking corporation with trust powers organized under the laws of the State of New York, serves as the Trustee. The Shares are backed by the assets of the Trust, which does not hold or use derivative products.

Advisors' Opinion:
  • [By Richard Cox]

    In ETFs, this translates to substantially bearish moves in PowerShares DB US Dollar Index Bullish (UUP) and highly bullish moves in theCurrencyShares Japanese Yen Trust (FXY). The BoJ left policy unchanged, with no stated plans to alter the 60 trillion Yen ($611 billion) in annual injections to the country's monetary base. Most analysts were expecting the BoJ would approve loan operations that extend to two years (or longer), and the results put renewed focus on the 10-year Japanese treasury note. Since the BoJ announced its historic stimulus plan in April, the 10-year note has risen from its all-time lows at 0.315% to highs of 1%. The main ideological thrust of the BoJ must be kept in perspective, however, as there is still clear long-term concern for the prospects of the country's export companies and pronounced efforts in place to bring consumer inflation levels back toward normal ranges.

Hot Managed Healthcare Stocks To Watch For 2014: Ubiquiti Networks Inc (UBNT)

Ubiquiti Networks, Inc. (Ubiquiti), incorporated on June 24, 2010, is a communications technology Company. designs, manufactures and sells broadband wireless solutions worldwide. The Company offers a portfolio of wireless networking products and solutions, including systems, high performance radios, antennas and management tools, designed for wireless networking and other applications in the unlicensed radio frequency (RF) spectrum. The Company offers solutions that incorporate its RF technology, antenna design and firmware technologies, which it refers to as AirTechnologies. It offers a portfolio of communications networking products and solutions and it recently introduced products in the video surveillance, wireless backhaul and machine-to-machine communication markets.

The Company�� business is driven by a community of network operators, service providers, distributors, value added resellers (VARs) and system integrators, which it refers to as the Ubiquiti Community. As of June 30, 2013, Ubiquiti�� AirTechnologies included, UBNT, airMAX, UniFi, mFi, EdgeMAX, airVision, airFiber, airOS, NanoStation, airGrid, NanoBridge, and a number of trademark applications and registrations in the United States and other countries. The Company technology enables it to provide end to end wireless networking solutions for network operators and service providers in underserved and underpenetrated markets. It designs its products and solutions using hardware and industry standard chipsets to enable these providers to deliver carrier class wireless broadband access and services to their subscribers.

Enterprise WLAN - UniFi

Unifi hardware utilizes MIMO technology, works with 802.11 standards, and uses a single cable for data transmission and power-over-ethernet. Unlike other enterprise Wi-Fi systems that utilize a hardware Wi-Fi switch, Unifi uses a virtual controller that allows for on-site management or remote management through the cloud. Each UniFi access point a! nd can be managed centrally with the UniFi Controller software. The UniFi Controller enables enterprise WLAN managers to centrally configure and administer a UniFi network and individual access points without any special training and through secure access from any Web browser. The UniFi Controller provides automatic UniFi access point detection, firmware updates, real-time status, map loading and advanced security options.

Video Surveillance - airVision

The H.264 cameras use a single cable for data transmission and power-over-ethernet. AirVision, its management controller software, can be used to manage multiple AirCam H.264 IP cameras as well as manage other digital video recorder devices. AirVision software is available for download at no cost on its Website and only manages Ubiquiti Network camera devices. Similar to its other network management products, airVision can be accessed securely from any Web browser, provides statistical reporting and analytics and provides a management console with camera settings and event recordings.

Machine-To-Machine Communication - mFi

In June 2012, the Company announced mFi, which includes hardware sensors, power devices, and management software that allows devices to be controlled remotely. For example, mFi allows users to manage and monitor their building temperature and power consumption. The management controller software is IP based and can be accessed from any browser locally or through the cloud. MFi software allows management to create rules using if/then statements to control numerous devices.

The Company competes with Motorola, Trango, Cisco Systems, Proxim, Mikrotikls, Senao, Ceragon Networks, DragonWave, Ruckus Wireless, TP-LINK Technologies CO., LTD, Andrew Corporation, PCTEL, Aruba Networks, Inc, Vivotek, Inc., Axis Communications AB , Mobotix Corp, Cambium Networks , SAF Tehnika, EnergyHub, Inc., AlertMe.com Ltd and Radio Waves Inc.

Advisors' Opinion:
  • [By Brian Pacampara]

    What: Shares of communications networking technologist Ubiquiti Networks (NASDAQ: UBNT  ) soared 23% today after its quarterly results and outlook topped Wall Street expectations.

  • [By Jon C. Ogg]

    Ubiquiti Networks Inc. (NASDAQ: UBNT) was given a cautious Neutral rating as well, and it had the least negative bias in Garcha’s call. He said:

No comments:

Post a Comment